Chunyan Trantien-Gu

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?

Targeting CTLA-4 in cancer: Is it the ideal companion for PD-1 blockade immunotherapy combinations?

Journal: International journal of cancer

Published: June 04, 2020

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Journal: JCI insight

Published: August 14, 2019

Targeting PD-1 in cancer: Biological insights with a focus on breast cancer.

Targeting PD-1 in cancer: Biological insights with a focus on breast cancer.

Journal: Critical reviews in oncology/hematology

Published: May 16, 2019

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy.

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy.

Journal: ESMO open

Published: May 09, 2019

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.

Journal: EBioMedicine

Published: September 12, 2018

Quantifying Tertiary Lymphoid Structure-Associated Genes in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissues.

Quantifying Tertiary Lymphoid Structure-Associated Genes in Formalin-Fixed Paraffin-Embedded Breast Cancer Tissues.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 25, 2018

Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.

Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients.

Journal: BMC cancer

Published: July 20, 2018

PD-1hiCXCR5-CD4+ TFH Cells Play Defense in Cancer and Offense in Arthritis.

PD-1hiCXCR5-CD4+ TFH Cells Play Defense in Cancer and Offense in Arthritis.

Journal: Trends in immunology

Published: August 02, 2017

The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes.

The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes.

Journal: eLife

Published: July 18, 2017

CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer.

CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer.

Journal: JCI insight

Published: November 07, 2016

Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.

Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.

Journal: Oncoimmunology

Published: August 19, 2016

FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders.

FOXP1 is a regulator of quiescence in healthy human CD4+ T cells and is constitutively repressed in T cells from patients with lymphoproliferative disorders.

Journal: European journal of immunology

Published: February 20, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026